Analyst Ratings for NovaBay Pharmaceuticals (nby)

nby Rating Summary

nby Price Target Summary

* Over Last 12-Mos
  |   Expand Research on nby
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $2.00 (+222.6%) * Over Last 12-Mos
Rating Score: 10 / 10
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
4/30/2015 Maxim Group New Coverage Buy
(N/A)
2.00
(N/A)
0.63 0.62 -1.59% Details
3/6/2013 Ascendiant Capital New Coverage Strong Buy
(N/A)
2.25
(N/A)
1.15 0.62 -46.09% Details
Like NBY Ratings? Also take a look at MCK, CAH, LNKD, ABC

NBY Ratings News